Heron challenges Qilu's US generic application for anti-nausea cancer drug
MLex Summary: Heron Therapeutics filed a patent infringement suit against Qilu Pharmaceutical in the District of Delaware on Friday in opposition to Qilu’s Abbreviated New Drug Application (ANDA) to sell a...To view the full article, register now.
Already a subscriber? Click here to view full article